Page 2 - Laurae Niklason News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Laurae niklason. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Laurae Niklason Today - Breaking & Trending Today

Humacyte's (HUMA) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. The brokerage currently has a $6.00 target price on the stock. A number of other research analysts also recently weighed in on HUMA. Piper Sandler raised Humacyte from an […] ....

United States , Bradyw Dougan , Piper Sandler , Laurae Niklason , American International Group Inc , Cantor Fitzgerald , Securities Exchange Commission , Manufacturers Life Insurance Company , Humacyte Inc , Free Report , Trading Down , Get Free Report , Director Brady , Exchange Commission , International Group , Capital Management , Humacyte Daily , Nasdaq Huma , Reiterated Rating ,

Humacyte (NASDAQ:HUMA) Receives Overweight Rating from Cantor Fitzgerald

Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They currently have a $6.00 price target on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 68.07% from the company’s previous close. Other […] ....

Laurae Niklason , Piper Sandler , York Mellon Corp , Blackrock Inc , Advisor Group Holdings Inc , Humacyte Inc , Securities Exchange Commission , Cantor Fitzgerald , Swiss National Bank , Citigroup Inc , Get Free Report , Exchange Commission , Group Holdings , National Bank , New York Mellon Corp , Humacyte Daily , Nasdaq Huma , Reiterated Rating ,

Insider Selling: Humacyte, Inc. (NASDAQ:HUMA) CEO Sells $2,098,240.32 in Stock

Insider Selling: Humacyte, Inc. (NASDAQ:HUMA) CEO Sells $2,098,240.32 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Laurae Niklason , Piper Sandler , Cantor Fitzgerald , Blackrock Inc , Vanguard Group Inc , Humacyte Inc , Securities Exchange Commission , Northern Trust Corp , Geode Capital Management , Get Free Report , Exchange Commission , Capital Management , Street Corp , Trust Corp , Humacyte Daily ,

Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 602,443 Shares

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) CEO Laura E. Niklason sold 602,443 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $3.39, for a total transaction of $2,042,281.77. Following the sale, the chief executive officer now directly owns 8,191,140 shares of […] ....

Laurae Niklason , Piper Sandler , Wells Fargo Company , Rokos Capital Management , Humacyte Inc , Osaic Holdings Inc , Cantor Fitzgerald , Imprint Wealth , Get Free Report , Trading Down , Humacyte Daily , Nasdaq Huma , Insider Trading , Nsider Trades ,

Humacyte (NASDAQ:HUMA) Raised to Neutral at Piper Sandler

Piper Sandler upgraded shares of Humacyte (NASDAQ:HUMA – Free Report) from an underweight rating to a neutral rating in a research note issued to investors on Monday, Marketbeat reports. The brokerage currently has $3.50 price objective on the stock, up from their previous price objective of $2.75. Separately, Cantor Fitzgerald initiated coverage on Humacyte in […] ....

Hong Kong , Laurae Niklason , Piper Sandler , Cantor Fitzgerald , United Asset Strategies Inc , Y Intercept Hong Kong Ltd , Securities Exchange Commission , Humacyte Company Profile , Kovack Advisors Inc , Sg Americas Securities , Kovitz Investment Group Partners , Humacyte Inc , Free Report , Stock Down , Get Free Report , Exchange Commission , Asset Strategies , Investment Group Partners , Intercept Hong Kong Ltd , Humacyte Daily , Nasdaq Huma ,